openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

News

Discover

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

Privacy Policy Data rights Terms of Use Feedback Cookie Policy Company Solutions Free assessment Investors Get the app Contact

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

New Journal

News

Discover

Civics

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

Privacy Policy Data rights Terms of Use Feedback Cookie Policy Company Solutions Free assessment Investors Get the app Contact

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌ — IJR News

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌

Reporting

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌

1 source·Updated Jul 1, 2026

Global healthcare giant Johnson & Johnson (J&J) announced on Tuesday that it will acquire Israeli startup V-Wave for up to $1.7 billion, in a strategic move by J&J to bolster its position in the fast-growing congestive…

In this story:

Coverage details

No bias-rated sources yet

Other: 1

Total sources1

Last updatedJul 1, 2026

Does this breakdown look right?

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Coverage

Independent Journal ReviewOtherJohnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌

Comments

Ask this story anything:

Free account · your comment posts right after signup

Pick a side

Best value email providers

Gmail

Outlook

708 votes · vote on the full ranking →